Mitochondrial complex 2 deficiency, nuclear type 3: genes and variants
Explore variant evidence for Mitochondrial complex 2 deficiency, nuclear type 3 across 2 analyzed proteins (SDHB, SDHD). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Mitochondrial complex 2 deficiency, nuclear type 3
SDHB: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
It transfers electrons from succinate oxidation through iron-sulfur centers toward ubiquinone in mitochondrial complex II. Heterozygous loss-of-function variants strongly predispose to paraganglioma and pheochromocytoma and can also increase renal-tumor and gastrointestinal-stromal-tumor risk.
7 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in SDHB have source records linked to Mitochondrial complex 2 deficiency, nuclear type 3. Association strength is not clinical gene validity.
SDHD: Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
It provides a membrane-anchoring component of succinate dehydrogenase and is required for normal complex II electron transfer. Germline loss-of-function variants, often showing a parent-of-origin effect, strongly predispose to head-and-neck paragangliomas and pheochromocytomas.
3 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in SDHD have source records linked to Mitochondrial complex 2 deficiency, nuclear type 3. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Mitochondrial complex 2 deficiency, nuclear type 3
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SDHB I127S | 127 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C192R | 192 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB P197S | 197 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB R217C | 217 | Interaction with SDHAF1 | Pathogenic / likely pathogenic (★★) |
| SDHB R46Q | 46 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB R230H | 230 | Pathogenic / likely pathogenic (★★) | |
| SDHB W200C | 200 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHD L107R | 107 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD P81L | 81 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD D92G | 92 | Transmembrane | Pathogenic / likely pathogenic |
Same protein, different disease
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHB variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (53 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHB variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (48 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHB variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (47 pathogenic / likely pathogenic).
- Inherited phaeochromocytoma and paraganglioma excluding NF1 also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (4 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (14 pathogenic / likely pathogenic).
- Paragangliomas with sensorineural hearing loss also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (13 pathogenic / likely pathogenic).
- Carney-Stratakis syndrome also has ClinVar records linked to SDHD variants; they fall mostly in different places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (11 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (11 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHD variants; they fall mostly in different places as the Mitochondrial complex 2 deficiency, nuclear type 3 variants (4 pathogenic / likely pathogenic).
Diseases related to Mitochondrial complex 2 deficiency, nuclear type 3
- Pheochromocytoma/paraganglioma syndrome, also linked to SDHB and SDHD
- Pheochromocytoma, also linked to SDHB and SDHD
- Carney-Stratakis syndrome, also linked to SDHB and SDHD
- Hereditary pheochromocytoma and paraganglioma, also linked to SDHB and SDHD
- Gastrointestinal stromal tumor, also linked to SDHB
- Cowden syndrome, also linked to SDHD
- Mitochondrial complex II deficiency, nuclear, also linked to SDHD
- Paragangliomas with sensorineural hearing loss, also linked to SDHD
- Inherited phaeochromocytoma and paraganglioma excluding NF1, also linked to SDHB
Frequently asked questions
Which genes have records linked to Mitochondrial complex 2 deficiency, nuclear type 3?
This view contains 2 analyzed proteins: SDHB, SDHD. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 55 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center